Crystal Rock Capital Management cut its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 31.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 24,215 shares of the pharmacy operator’s stock after selling 11,100 shares during the quarter. Walgreens Boots Alliance comprises about 1.2% of Crystal Rock Capital Management’s investment portfolio, making the stock its 28th largest position. Crystal Rock Capital Management’s holdings in Walgreens Boots Alliance were worth $1,870,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently bought and sold shares of WBA. Pathstone Family Office LLC grew its stake in Walgreens Boots Alliance by 226.6% in the 2nd quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock valued at $1,969,000 after acquiring an additional 818 shares during the last quarter. Hudock Capital Group LLC grew its stake in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 6 shares during the last quarter. Westside Investment Management Inc. grew its stake in Walgreens Boots Alliance by 10.4% in the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 125 shares during the last quarter. Bristlecone Advisors LLC acquired a new stake in Walgreens Boots Alliance in the 3rd quarter valued at about $135,000. Finally, Hanson McClain Inc. grew its stake in Walgreens Boots Alliance by 4.6% in the 2nd quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock valued at $156,000 after acquiring an additional 87 shares during the last quarter. 61.18% of the stock is currently owned by institutional investors and hedge funds.
WBA has been the topic of a number of research reports. Morgan Stanley cut shares of Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $95.00 to $85.00 in a research note on Friday, October 6th. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, November 10th. Vetr raised shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, December 12th. Robert W. Baird reissued an “outperform” rating and issued a $80.00 price objective (down from $90.00) on shares of Walgreens Boots Alliance in a research note on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup decreased their price target on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research note on Thursday, November 2nd. One analyst has rated the stock with a sell rating, eight have given a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Buy” and a consensus price target of $86.05.
Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $72.92 on Friday. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00. The stock has a market cap of $73,550.00, a PE ratio of 20.14, a price-to-earnings-growth ratio of 1.35 and a beta of 1.22. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the company earned $1.10 EPS. sell-side analysts predict that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th were issued a dividend of $0.40 per share. The ex-dividend date was Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.19%. Walgreens Boots Alliance’s payout ratio is currently 44.20%.
Walgreens Boots Alliance declared that its Board of Directors has authorized a stock buyback program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its stock is undervalued.
COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance Inc (WBA) Stake Decreased by Crystal Rock Capital Management” was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another website, it was stolen and republished in violation of US and international copyright laws. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/3128158/walgreens-boots-alliance-inc-wba-stake-decreased-by-crystal-rock-capital-management.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.